To examine whether the mice with Ash1l loss in the brain were more likely to develop epilepsy, we challenged both wild-type and mutant mice by intraperitoneal injection of PTZ, a GABAA receptor antagonist, at a sub-convulsant dose (40 mg/kg) to induce seizures (Sansig et al., 2001). Here, ASH1L is linked to epilepsy.